Search Results 171-180 of 16286 for monoclonal antibody
Lack of observed interference by therapeutic monoclonal antibodies ... Monoclonal antibody therapeutics as potential interferences on protein electrophoresis and ...
Rituximab-arrx is a monoclonal antibody. Rituximab-arrx injection is also used together with other medicines (eg, fludarabine and cyclophosphamide) to treat ...
... monoclonal antibody therapy called sotrovimab, as well as an oral antiviral drug called Paxlovid and an IV antiviral drug called remdesivir. These drugs are ...
Monoclonal antibodies, such as blinatumomab, may block cancer growth in different ways by targeting certain cells. It is not yet known whether combination ...
The safety and efficacy of REGN5458, a monoclonal antibody, which has been used in people who already have been treated for multiple myeloma. Several ...
... monoclonal antibody therapy, such as trastuzumab emtansine (T-DM1) and/or pertuzumab. Participation eligibility. Participant eligibility includes age, gender ...
Monoclonal antibodies, such ... No prior treatment with an immune checkpoint inhibitor (anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CTLA4 monoclonal antibody).
Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...
... monoclonal antibody) in subjects with relapsed or refractory Multiple Myeloma. ... Monoclonal antibodies, such as pembrolizumab, may interfere with the ...
This medicine is a monoclonal antibody that works on the immune system. This medicine is to be given only by or under the direct supervision of your doctor ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Their crucial work saves lives every day. Let Mayo Clinic researchers know they’re appreciated with a quick message.